These studies validated our proposed hypothesis that telomerase activity can be repressed in infiltrating ductal carcinoma cells via transcriptional regulation of hTERT utilizing protein transduction techniques with E2F-1 Tat fusion proteins. The gene discussed is E2F1; the disease is invasive ductal breast carcinoma.